Farallon Capital Management’s Immunomedics Inc IMMU Stock Holding History

Farallon Capital Management’s Portfolio IMMU Stock Details IMMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-5,860,000	Closed	-$498M	–	165
2020 Q3	$498M	Buy	+5,860,000	New	+$296M	3.45%	3
2018 Q3	–	Sell	-400,000	Closed	-$9.47M	–	115
2018 Q2	$9.47M	Buy	+400,000	New	+$8.04M	0.06%	79
2017 Q3	–	Sell	-4,227,500	Closed	-$37.3M	–	95
2017 Q2	$37.3M	Buy	4,227,500 +72,500	+2%	+$509K	0.39%	43
2017 Q1	$26.9M	Buy	+4,155,000	New	+$21M	0.29%	51

Farallon Capital Management's IMMU Position: Q4 2020 in Review

Farallon Capital Management sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 5,860,000 shares — an estimated $498M sold.

Farallon Capital Management first reported a position in IMMU in Q1 2017 and held it in 4 quarters. The position peaked at $498M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

Farallon Capital Management reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
Farallon Capital Management sold 5,860,000 Immunomedics Inc shares in Q4 2020, an estimated $498M.
Farallon Capital Management first reported a position in Immunomedics Inc in Q1 2017 and held it in 4 quarters.
Farallon Capital Management's Immunomedics Inc position peaked at $498M in Q3 2020.
0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Farallon Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.